Biotia raises $9 million to expand metagenomics testing, advance reimbursement, and broaden diagnostics in women’s health and ...
A study found the AidaBREAST test can assess 10-year recurrence risk and predict radiation therapy benefit in early-stage ...
China’s NMPA has approved Quanterix and Innovita’s HD-X and SR-X instruments and four blood-based neurology assays for use in ...
A study demonstrates correlation between measurements of biologically active ET-1 generated using Olink proximity extension ...
Clinisys adds document intelligence to its Laboratory Solution, enabling labs to convert documents into searchable, governed ...
A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.
A peer-reviewed study reports ACES Diagnostics’ LymeSeek test achieved 90% sensitivity for early Lyme disease detection.
Roche supplied two molecular testing systems and in the DRC to support PCR test validation for Bundibugyo virus amid Ebola outbreak.
Cerenome's CNSide Diagnostics launched two CSF-based molecular profiling tests for CNS cancers, analyzing DNA and RNA.
The oncoReveal Myeloid v2 NGS panel expands coverage to 80 genes and improving FLT3-ITD detection for myeloid malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results